Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases
British Journal of Surgery · 2024
DOI: 10.1093/bjs/znae016 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, 2024. Verfasst von Berta Martín-Cullell und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Histopathological and molecular features have been proposed to hold prognostic information, but few have been validated. The aim of this retrospective study was to validate the Genetic And Morphological Evaluation (‘GAME’) score and assess the impact of histological characteristics on the prognosis in patients with colorectal liver metastases.
Methods
Data were collected from 176 patients with metastatic colorectal cancer undergoing liver resection at Hospital de la Santa Creu i Sant Pau. Patients were classified into Genetic And Morphological Evaluation score groups and relapse-free survival and overall survival were calculated. Histopathological changes in colorectal liver metastases were documented and prognostic variables were selected to create a post-surgery score, called the Histopathological, Clinical, And Molecular (‘HICAM’) score.
Results
Regarding the Genetic And Morphological Evaluation score, the high-risk group had a median relapse-free survival of 8.8 months, compared with 20.5 months for the low-risk group (P = 0.005), and the high-risk group had a median overall survival of 37.8 months, compared with 67.0 months for the low-risk group (P = 0.005). Histological examination of 144 liver samples showed that the desertic immune phenotype was associated with worse overall survival in the multivariable analysis (P = 0.020). The Histopathological, Clinical, And Molecular score variables were age at diagnosis, tumour burden score, carcinoembryonic antigen levels greater than or equal to 20 ng/ml, primary tumour resection, TNM stage at diagnosis, molecular status, histopathological growth patterns, and immune phenotypes of the liver. The high-risk group had a median relapse-free survival of 8.4 months, compared with 20.4 months for the low-risk group (P < 0.001), and a median overall survival of 30.4 months, compared with 105.0 months for the low-risk group (P < 0.001).
Conclusion
The Genetic And Morphological Evaluation score was validated as a preoperative prognostic tool to predict candidacy for liver resection. The Histopathological, Clinical, And Molecular score could be useful to assess adjuvant treatment after hepatic resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.
- Department of Medicine, Universitat Autónoma de Barcelona, Barcelona, Spain.
- Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- U705, Instituto de Salud Carlos III, Center for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain.
- Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
ORCID-Profile: Berta Martín-Cullell, Pau Riera, David Páez
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Martín-Cullell, B., Virgili, A. C., Riera, P., Fumagalli, C., Mirallas, O., Pelegrín, F. J., Sánchez-Cabús, S., Molina, V., Szafranska, J., & Páez, D. (2024). Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases. British Journal of Surgery. https://doi.org/10.1093/bjs/znae016
Vancouver
Martín-Cullell B, Virgili AC, Riera P, Fumagalli C, Mirallas O, Pelegrín FJ, et al. Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases. British Journal of Surgery. 2024. doi:10.1093/bjs/znae016
BibTeX
@article{MartnCullell2024,
author = {Martín-Cullell, Berta and Virgili, Anna C and Riera, Pau and Fumagalli, Caterina and Mirallas, Oriol and Pelegrín, Francisco J and Sánchez-Cabús, Santiago and Molina, Víctor and Szafranska, Justyna and Páez, David},
title = {Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases},
journal = {British Journal of Surgery},
year = {2024},
doi = {10.1093/bjs/znae016}
}
EUVIMED